IDNA

iShares Genomics Immunology and Healthcare ETF
NYSEArcaUSDETF / FUND DELAYED
Last price
40.87
▼ 1.85 (4.33%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
42.72
Day high
43.41
Day low
40.70
Volume
198.27K
Market cap
—
P/E (TTM)
26.26
52W range
23.90 – 43.41

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.13% -6.1%
1M
+2.77% +1.6%
3M
+19.33% +14.8%
6M
+41.32% +23.1%
YTD
+56.05% +41.8%
1Y
+65.87% +49.4%
3Y
+100.84% +18.6%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
MRNA Moderna Inc 11.20%
TWST Twist Bioscience Corp 7.70%
IOVA Iovance Biotherapeutics Inc 4.98%
GMAB.CO Genmab AS 3.98%
RVMD Revolution Medicines Inc Ordinary Shares 3.79%
BAYN.DE Bayer AG 3.60%
MRK Merck & Co Inc 3.32%
4502.T Takeda Pharmaceutical Co Ltd 3.30%
REGN Regeneron Pharmaceuticals Inc 3.29%
INCY Incyte Corp 3.27%

Sector exposure

Fund weightings
Healthcare
100.00%

Fund profile

As reported
Fund familyiShares
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.47%
Turnover49.0%
Total net assets$18.20M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on IDNA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E26.26
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
35.00
-14.4% from spot
ATM implied vol
0.8%
Nearest strike to spot
Skew (10% OTM)
+5.5%
Puts bid over calls
Call volume
87
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
35.00
0 contracts
Heaviest put OI
39.00
0 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
41.79
-2.19% from price
SMA 20
40.53
+0.84% from price
SMA 50
38.32
+6.67% from price
SMA 100
34.77
+17.56% from price
SMA 200
31.91
+28.07% from price
EMA 12
41.41
-1.30% from price
EMA 26
40.39
+1.18% from price
EMA 50
38.64
+5.77% from price
RSI (14)
53.2
Neutral
MACD (12,26,9)
1.01
Hist -0.08
ATR (14)
1.16
2.84% of price
Realised vol 30D
31.3%
Annualised
Bollinger upper
43.66
20, 2σ
Bollinger lower
37.40
20, 2σ
50 / 200 cross
Golden
38.32 vs 31.91
Trend bias
Above 200
+28.07%

Options chain

Account required
Expiry
Spot 40.87
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.98
Less volatile than market
Correlation to SPY
0.44
Loosely linked
Realised vol 30D
31.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-10.7%
Peak to trough
Max drawdown 5Y
-66.2%
Peak to trough
ATR 14
1.16
2.84% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.